# Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine

> **NCT05667246** · NA · ENROLLING_BY_INVITATION · sponsor: **Weill Medical College of Cornell University** · enrollment: 52 (estimated)

## Conditions studied

- Terbinafine Adverse Reaction

## Interventions

- **OTHER:** Caffeinated Coffee
- **OTHER:** Decaffeinated Coffee

## Key facts

- **NCT ID:** NCT05667246
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667246, "Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05667246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*